相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High-throughput analysis identifying drugs that reduce oxidative and ER stress in human coronary artery endothelial cells
Michael J. Haas et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Synergy between Auranofin and Celecoxib against Colon Cancer In Vitro and In Vivo through a Novel Redox-Mediated Mechanism
Yi Han et al.
CANCERS (2019)
Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines
Antonio Buzharevski et al.
CHEMMEDCHEM (2019)
Therapeutic Targeting of Cellular Stress to Prevent Cardiovascular Disease: A Review of the Evidence
Arshag D. Mooradian
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2017)
Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β-catenin signaling pathway
Issei Egashira et al.
CANCER SCIENCE (2017)
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM( Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial
Frank Ruschitzka et al.
EUROPEAN HEART JOURNAL (2017)
Celecoxib induces apoptosis but up-regulates VEGF via endoplasmic reticulum stress in human colorectal cancer in vitro and in vivo
Bingfei Xu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis
Steven E. Nissen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Mitochondrial toxicity of selective COX-2 inhibitors via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria
Muzeeb Syed et al.
TOXICOLOGY IN VITRO (2016)
ERK/Ribosomal S6 Kinase (RSK) Signaling Positively Regulates Death Receptor 5 Expression through Co-activation of CHOP and Elk1
You-Take Oh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Oxidized Low-Density Lipoproteins Trigger Endoplasmic Reticulum Stress in Vascular Cells Prevention by Oxygen-Regulated Protein 150 Expression
Marie Sanson et al.
CIRCULATION RESEARCH (2009)
Celecoxib transiently inhibits cellular protein synthesis
Peter Pyrko et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Celecoxib and a novel COX-2 inhibitor ON09310 upregulate death receptor 5 expression via GADD153/CHOP
Q. He et al.
ONCOGENE (2008)
Effects of selective COX-2 inhibition on prostanoids and platelet physiology in young healthy volunteers
J. Graff et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome
Masafumi Myoishi et al.
CIRCULATION (2007)
Celecoxib for the prevention of colorectal adenomatous polyps
Nadir Arber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Real-time detection and continuous monitoring of ER stress in vitro and in vivo by ES-TRAP: evidence for systemic, transient ER stress during endotoxemia
Nobuhiko Hiramatsu et al.
NUCLEIC ACIDS RESEARCH (2006)
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition
DL Simmons et al.
PHARMACOLOGICAL REVIEWS (2004)
Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay:: determination of cyclo oxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer
LJ Murphey et al.
ANALYTICAL BIOCHEMISTRY (2004)
Rofecoxib: an update on physicochemical, ISSN pharmaceutical, pharmacodynamic and pharmacokinetic aspects
N Ahuja et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2003)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors
BJR Whittle
GUT (2000)
分享论文
